Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of artificial intelligence in the therapy of oropharyngeal squamous cell carcinoma: De-escalation via Claude 3 Opus, Vertex AI and ChatGPT 4.0? - an experimental study.
Schmidl B, Hütten T, Pigorsch S, Stögbauer F, Hoch CC, Hussain T, Wollenberg B, Wirth M. Schmidl B, et al. Among authors: hutten t. Int J Surg. 2024 Dec 1;110(12):8256-8260. doi: 10.1097/JS9.0000000000002139. Int J Surg. 2024. PMID: 39806758 Free PMC article. No abstract available.
Assessing the use of the novel tool Claude 3 in comparison to ChatGPT 4.0 as an artificial intelligence tool in the diagnosis and therapy of primary head and neck cancer cases.
Schmidl B, Hütten T, Pigorsch S, Stögbauer F, Hoch CC, Hussain T, Wollenberg B, Wirth M. Schmidl B, et al. Among authors: hutten t. Eur Arch Otorhinolaryngol. 2024 Nov;281(11):6099-6109. doi: 10.1007/s00405-024-08828-1. Epub 2024 Aug 7. Eur Arch Otorhinolaryngol. 2024. PMID: 39112556 Free PMC article.
Assessing the role of advanced artificial intelligence as a tool in multidisciplinary tumor board decision-making for recurrent/metastatic head and neck cancer cases - the first study on ChatGPT 4o and a comparison to ChatGPT 4.0.
Schmidl B, Hütten T, Pigorsch S, Stögbauer F, Hoch CC, Hussain T, Wollenberg B, Wirth M. Schmidl B, et al. Among authors: hutten t. Front Oncol. 2024 Sep 5;14:1455413. doi: 10.3389/fonc.2024.1455413. eCollection 2024. Front Oncol. 2024. PMID: 39301542 Free PMC article.
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity.
van Ens D, Mousset CM, Hutten TJA, van der Waart AB, Campillo-Davo D, van der Heijden S, Vodegel D, Fredrix H, Woestenenk R, Parga-Vidal L, Jansen JH, Schaap NPM, Lion E, Dolstra H, Hobo W. van Ens D, et al. Among authors: hutten tja. Bone Marrow Transplant. 2020 Dec;55(12):2308-2318. doi: 10.1038/s41409-020-0966-6. Epub 2020 Jun 11. Bone Marrow Transplant. 2020. PMID: 32528120
Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation.
Hutten TJA, Norde WJ, Woestenenk R, Wang RC, Maas F, Kester M, Falkenburg JHF, Berglund S, Luznik L, Jansen JH, Schaap N, Dolstra H, Hobo W. Hutten TJA, et al. Biol Blood Marrow Transplant. 2018 Apr;24(4):666-677. doi: 10.1016/j.bbmt.2017.11.027. Epub 2017 Dec 26. Biol Blood Marrow Transplant. 2018. PMID: 29197680 Free article.
18 results